coronary artery disease

In a large clinical trial involving patients with coronary artery disease, use of B vitamins was not effective for preventing death or cardiovascular events, according to a study published in the Aug. 20 issue of JAMA.

Patients treated solely with medications after suffering from chest pain, heart attack or coronary artery disease are more likely to die during the first year following their initial hospitalization.

Researchers found that with all else being equal, the risk of death was highest for the medically managed group and lowest for patients who underwent stenting.

Postmenopausal women are at an increased risk of developing coronary artery disease, yet recent research studies have sometimes resulted in conflicting data regarding how best to treat or minimize the effects of the disease.

Researchers induced stress in 148 patients with coronary artery disease by asking them to speak in public. Those with a particular gene variation were three times more likely to experience dangerous decreases in blood flow to the heart during stress.

The anti-obesity medication rimonabant showed mixed results in slowing progression of coronary artery disease in patients with abdominal obesity and pre-existing coronary disease, according to a new study.

The gene for the HDL-associated protein paraoxonase 1 appears to be associated with coronary artery disease and with the risk of developing adverse cardiac events, and variations in both the PON1 gene and its related enzyme activity may increase the risk for cardiovascular disease events.

Thousands of research studies have documented how the oils known as omega-3 fatty acids can benefit the cardiovascular system, particularly among people diagnosed with coronary artery disease.

Women and men experience a similar prevalence of adverse drug reactions in the treatment of coronary artery disease; however, women are significantly less likely than their male counterparts to be treated with statins, aspirin, and beta-blockers according to a new study.